Cellectis (CLLS) Dividends Paid - Common (2015 - 2026)
Cellectis (CLLS) posted quarterly Dividends Paid - Common of $34.8 million for Q1 2026, down 72.7% year-over-year from $127.6 million in Q1 2025, and up 560.49% quarter-over-quarter from -$7.6 million in Q3 2025.
Cellectis (CLLS) Dividends Paid - Common (2015 - 2026) Analysis & Trends
Cellectis' Dividends Paid - Common history runs 12 years deep, the most recent figure standing at $34.8 million for Q1 2026.
- In Q1 2026, Dividends Paid - Common fell 72.7% year-over-year to $34.8 million; the TTM figure through Mar 2026 stood at $87.1 million (down 69.63% YoY), while the FY2016 annual figure was $267.4 million, down 23.41% from the prior year.
- Dividends Paid - Common for Q1 2026 stood at $34.8 million, up from -$7.6 million in the prior quarter.
- The five-year high for Dividends Paid - Common was $154.9 million in Q1 2022, with the low at -$67.8 million in Q2 2025.
- The 5-year median for Dividends Paid - Common is $10.0 million (2024), against an average of $31.6 million.
- The sharpest annual moves came in 2024 and 2025: Dividends Paid - Common soared 2301.94% in 2024, then slumped 360.16% in 2025.
- Cellectis' Dividends Paid - Common stood at -$31.8 million in 2022, then soared by 46.44% to -$17.0 million in 2023, then jumped by 158.99% to $10.0 million in 2024, then plunged by 175.32% to -$7.6 million in 2025, then soared by 560.49% to $34.8 million in 2026.
- Business Quant data shows CLLS's Dividends Paid - Common at $34.8 million in Q1 2026, -$7.6 million in Q3 2025, and -$67.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 96.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 34.60 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Cellectis | 306.61 Mn | 120.95 Mn | - | 34.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.84 Mn |
| Mar 31, 2026 | 34.84 Mn |
| Sep 30, 2025 | -7.57 Mn |
| Sep 30, 2025 | -7.57 Mn |
| Jun 30, 2025 | -67.83 Mn |
| Jun 30, 2025 | -67.83 Mn |
| Mar 31, 2025 | 127.64 Mn |
| Mar 31, 2025 | 127.64 Mn |
| Sep 30, 2024 | 10.05 Mn |
| Sep 30, 2024 | 10.05 Mn |
| Jun 30, 2024 | 26.07 Mn |
| Jun 30, 2024 | 26.07 Mn |
| Mar 31, 2024 | 122.97 Mn |
| Mar 31, 2024 | 122.97 Mn |
| Sep 30, 2023 | -17.03 Mn |
| Sep 30, 2023 | -17.03 Mn |
| Jun 30, 2023 | -1.18 Mn |
| Jun 30, 2023 | -1.18 Mn |
| Mar 31, 2023 | 85.57 Mn |
| Mar 31, 2023 | 85.57 Mn |